AEBP1 and metabolic dysfunction-associated steatotic liver disease: To extend AEBP1 expression findings from human liver biopsy tissue, we used in vitro models of diabetes and NAFLD by assaying the effects of glucose, fructose, and palmitate treatments on human stellate and liver cells.